Purpose

The overarching goal of this research is to use machine learning analysis of high-resolution data-collected by wearable technology-of cardiothoracic surgical patients to assess recovery and detect complications at their earliest stage

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Age 18 years or older undergoing cardiothoracic surgery that is male or a non-pregnant female and are amenable to using one of the wearable devices of interest (Fitbit, iWatch, Biostrap). 2. Individuals willing to provide informed consent and who have capacity for all study procedures

Exclusion Criteria

  1. Individuals with mental incapacity and/or cognitive impairment that would preclude adequate understanding of, or cooperation with the study protocol. 2. Any pregnant participant. 3. Severe irreversible pulmonary hypertension. 4. Congenital heart disease 5. Chronic renal insufficiency or undergoing chronic renal replacement therapy 6. Liver cirrhosis

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Cardiothoracic Surgery Cohort Adults patients who are scheduled to undergo cardiothoracic surgery and meet the inclusion and exclusion criteria.
  • Device: Device: Wearable Device
    A Wearable Device will be placed on the wrist of the patient ~30 days prior to the patient's scheduled surgery, removed during the operation, and replaced for ~180 days post-operatively. The device will record activity in terms of steps, sleep quality, heart rate, etc.

Recruiting Locations

Massachusetts General Hospital
Boston, Massachusetts 02114
Contact:
Chi-Fu J Yang, M.D.
814-574-8695
cjyang@mgh.harvard.edu

More Details

Status
Recruiting
Sponsor
Massachusetts General Hospital

Study Contact

Chi-Fu Jeffrey Yang, MD
617-726-5200
cjyang@mgh.harvard.edu

Detailed Description

This is a single-center non-randomized prospective cohort study using wearable devices in cardiothoracic surgery patients to detect post-operative complications. Patients undergoing cardiothoracic surgery who meet the inclusion and exclusion criteria will be enrolled consecutively with verbal informed consent from the time this protocol is approved by the IRB until 1,200 subjects are enrolled. At ~30 days preoperatively the subjects will have a wearable device (such as a Fitbit) placed on their wrist and will wear the device until ~180 days post-operatively. This device will wirelessly transmit data regarding activity and sleep quality to a smartphone application for the duration of wear and data will be analyzed by our collaborators at Case Western Reserve University.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.